Efficacy and Safety of the Proposed Biosimilar Pertuzumab (PERT-IJS) Versus EU-Perjeta® Along With Trastuzumab and Chemotherapy (Carboplatin and Docetaxel) as Neoadjuvant Treatment in Chemotherapy naïve Patients With Early Stage or Locally Advanced HR Negative and HER2 Positive Breast Cancer
Phase 3 Terminated
55 enrolled
A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors
Phase 1 Terminated
157 enrolled
Efficacy and Safety of TQB2450 Injection Combined With Chemotherapy ± Anlotinib Hydrochloride Capsules for Advanced Endometrial Cancer or Sarcoma of Uterus.
Phase 2 Terminated
71 enrolled
ELEVATE HNSCC
Phase 2 Terminated
193 enrolled 27 charts
Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma
Phase 2 Terminated
96 enrolled 17 charts
GeoMETry-III
Phase 3 Terminated
22 enrolled 22 charts
ELEVATELung&UC
Phase 2 Terminated
106 enrolled 22 charts
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
FORTITUDE-201
Phase 1 Terminated
74 enrolled 22 charts
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
Phase 1/2 Terminated
36 enrolled 26 charts
Acclaim-2
Phase 1/2 Terminated
5 enrolled
LUME-Columbus: Nintedanib Plus Docetaxel in Advanced Non-small Cell Lung Cancer With Translational Research
Phase 3 Terminated
12 enrolled 7 charts
A Dose Escalation Study Of PF-06939999 In Participants With Advanced Or Metastatic Solid Tumors
Phase 1 Terminated
54 enrolled 42 charts
A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies
Phase 1 Terminated
21 enrolled
Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 18 charts
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
Phase 1 Terminated
30 enrolled
Study of AG-270 in Participants With Advanced Solid Tumors or Lymphoma With MTAP Loss
Phase 1 Terminated
123 enrolled
KEYNOTE-921
Phase 3 Terminated
81 enrolled 19 charts
Compare the Efficacy and the Safety of Taxotere and Nanoxel M as Neoadjuvant Chemotherapy in Breast Cancer
Phase 3 Terminated
26 enrolled
A Phase II Study of Envofolimab and BD0801 With/Without Chemotherapy in Patients With Advanced Solid Tumors
Phase 2 Terminated
86 enrolled
SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer
Phase 3 Terminated
188 enrolled
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma
Phase 1/2 Terminated
23 enrolled 15 charts
CANOPY-2
Phase 3 Terminated
245 enrolled 29 charts
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC
Phase 3 Terminated
1 enrolled
KN046 Plus Lenvatinib in Subject With Advanced Non-Small Cell Lung Cancer in the Failure of Anti-PD-(L)1 Agent
Phase 2/3 Terminated
16 enrolled
PRESERVE 4
Phase 2 Terminated
10 enrolled 14 charts
GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer
Phase 1 Terminated
53 enrolled
A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer
Phase 1 Terminated
6 enrolled
Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast Cancer
Phase 2 Terminated
33 enrolled
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Phase 1 Terminated
16 enrolled
Intratumoural Injection of a Novel NanoZolid®-Docetaxel Depot Formulation in Patients With Advanced Solid Tumours
Phase 1 Terminated
6 enrolled
Study of HL-085 Plus Docetaxel in Patients With KRAS Mutant NSCLC
Phase 1 Terminated
2 enrolled
A Study of LY3499446 in Participants With Advanced Solid Tumors With KRAS G12C Mutation
Phase 1/2 Terminated
5 enrolled 9 charts
Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
Phase 2 Terminated
34 enrolled
Phase II Study of SPI-1620 in Combination With Docetaxel as a Second-Line to Treat Biliary Cancer
Phase 2 Terminated
30 enrolled
SHERLOC
Phase 2 Terminated
153 enrolled 19 charts
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Phase 4 Terminated
4 enrolled 9 charts
INDUCT
Phase 2 Terminated
66 enrolled 40 charts
ATTRACT-2
Phase 3 Terminated
900 enrolled
TroVax® In Subjects With Hormone Refractory Prostate Cancer (HRPC)
Phase 2 Terminated
25 enrolled
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
Phase 2/3 Terminated
135 enrolled
FIERCE-21
Phase 1/2 Terminated
71 enrolled 9 charts
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Phase 2 Terminated
66 enrolled 17 charts
TIGER-3: Open Label, Multicenter Study of Rociletinib (CO-1686) Mono Therapy Versus Single-agent Cytotoxic Chemotherapy in Patients With Mutant EGFR NSCLC Who Have Failed at Least One Previous EGFR-Directed TKI and Platinum-doublet Chemotherapy
Phase 3 Terminated
149 enrolled 17 charts
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
Phase 2 Terminated
59 enrolled 9 charts
A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer
Phase 1 Terminated
30 enrolled 29 charts
GSK1120212 Rollover Study
Phase 2 Terminated
159 enrolled 9 charts
PRIMAL
Phase 1 Terminated
16 enrolled 12 charts
SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Cancer
Phase 3 Terminated
12 enrolled
A Safety Study in Participants With Advanced Solid Tumors
Phase 1 Terminated
234 enrolled 23 charts